Article

Age, family history primary factors in development of AMD

Fort Lauderdale, FL—Numerous factors have been studied to determine an association with the development of age-related macular degeneration (AMD), according to Barbara Klein, MD, MPH. Family history, however, is by far the factor that stands out among the crowded arena of suspects. She reported why this is the case at the annual meeting of the Association for Research in Vision and Ophthalmology.

Fort Lauderdale, FL-Numerous factors have been studied to determine an association with the development of age-related macular degeneration (AMD), according to Barbara Klein, MD, MPH. Family history, however, is by far the factor that stands out among the crowded arena of suspects. She reported why this is the case at the annual meeting of the Association for Research in Vision and Ophthalmology.

When the AMD epidemiology literature is reviewed, three common risk factors crop up for the disease: age, family history, and smoking. Numerous potential risks factors have been considered as causes of AMD, including: atherosclerosis, serum lipids, pulmonary disease, blood pressure, gout, arthritis, body mass index, inflammatory factors, alcohol intake, caffeine, physical activity level, hormone replacement therapy, diet and dietary supplements, light exposure, iris color, presence of cataract, refraction, and some sociodemographic factors. With most, the findings among studies were inconsistent.

One of the most consistent findings has been the impact of smoking, which has been found to be related to early and late AMD lesions in many but not all studies. The prevalence and incidence findings are not consistent, said Dr. Klein, professor, department of ophthalmology, University of Wisconsin, Madison.

Three studies have been published and another is about to be published concerning a polymorphism encoding complement factor H in region 1q25-31 that appears to be associated with AMD in some families, she said. Also, a variant in the toll-like receptor region at 9q32 appears to be associated with increased risk of AMD, but another variant is not, she continued.

Dr. Klein and her colleagues looked at the genetics of AMD in a study of affected families. In the Family Age-Related Macular Degeneration Study (FARMS), which included 32 affected families that were highly ascertained, the investigators found that only three families had a link to the peak on 1q. In the Beaver Dam Eye Study, in which 602 families (2,300 people) that were not ascertained participated, analysis of the CIH locus is pending, however linkage to markers in regions 1p35 and 15q22 has been found. The FARMS families also have a peak on chromosome 15, Dr. Klein explained.

Genetic, environmental factors

"The influence of any particular gene may depend on the effects of other genes and environmental factors. An approach that embraces personal and environmental factors and modifier genes influencing disease expression is likely to be the most informative way to find out more about macular degeneration," she said.

Factors that still need to be considered, she advised, as the research into AMD continues, are understanding the ascertainment methods and biases for the patients involved in the various studies of AMD; if there are genotypic and phenotypic heterogeneity problems that have an impact on the study results; why common variants in genes are associated with disease only in some patients; why early AMD lesions progress to late lesions in some patients only; and what other risk factors-either genetic or environmental-affect risk or change the expression.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.